A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
Clinical trial NCT06797869 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06797869
- Sponsor
- Novo Nordisk A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-29
- Primary completion
- 2026-08-21
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.